These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25030735)

  • 1. Overexpression of RFC3 is correlated with ovarian tumor development and poor prognosis.
    Shen H; Cai M; Zhao S; Wang H; Li M; Yao S; Jiang N
    Tumour Biol; 2014 Oct; 35(10):10259-66. PubMed ID: 25030735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma.
    Zhao Y; Chen S; Gou WF; Xiao LJ; Takano Y; Zheng HC
    Tumour Biol; 2014 Mar; 35(3):1955-64. PubMed ID: 24132590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of SGLT1 is correlated with tumor development and poor prognosis of ovarian carcinoma.
    Lai B; Xiao Y; Pu H; Cao Q; Jing H; Liu X
    Arch Gynecol Obstet; 2012 May; 285(5):1455-61. PubMed ID: 22159627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYR61 overexpression associated with the development and poor prognosis of ovarian carcinoma.
    Shen H; Cai M; Zhao S; Wang H; Li M; Yao S; Jiang N
    Med Oncol; 2014 Aug; 31(8):117. PubMed ID: 25048722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of Beclin 1 correlates closely with Bcl-xL expression and poor prognosis of ovarian carcinoma.
    Lin HX; Qiu HJ; Zeng F; Rao HL; Yang GF; Kung HF; Zhu XF; Zeng YX; Cai MY; Xie D
    PLoS One; 2013; 8(4):e60516. PubMed ID: 23573264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
    Li T; Xue H; Guo Y; Guo K
    Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.
    Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K
    J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer.
    Hou T; Yang C; Tong C; Zhang H; Xiao J; Li J
    Int J Clin Exp Pathol; 2014; 7(1):280-7. PubMed ID: 24427349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss/Down-regulation of tumor suppressor in lung cancer 1 expression is associated with tumor progression and is a biomarker of poor prognosis in ovarian carcinoma.
    Yang G; He W; Cai M; Luo F; Kung H; Guan X; Zeng Y; Xie D
    Int J Gynecol Cancer; 2011 Apr; 21(3):486-93. PubMed ID: 21436696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of SLC12A5 is associated with tumor progression and poor survival in ovarian carcinoma.
    Yang GP; He WP; Tan JF; Yang ZX; Fan RR; Ma NF; Wang FW; Chen L; Li Y; Shen HW; You ZS; Xie D; Yang GF
    Int J Gynecol Cancer; 2019 Oct; 29(8):1280-1284. PubMed ID: 31570543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer.
    Xu Y; Wang C; Zhang Y; Jia L; Huang J
    Sci Rep; 2015 Jul; 5():12104. PubMed ID: 26175056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
    Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
    Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients.
    Chen YJ; Chen CM; Twu NF; Yen MS; Lai CR; Wu HH; Wang PH; Yuan CC
    Virchows Arch; 2009 Nov; 455(5):431-40. PubMed ID: 19838728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
    Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J
    Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase IIalpha mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis.
    Faggad A; Darb-Esfahani S; Wirtz R; Sinn B; Sehouli J; Könsgen D; Lage H; Weichert W; Noske A; Budczies J; Müller BM; Buckendahl AC; Röske A; Eldin Elwali N; Dietel M; Denkert C
    Mod Pathol; 2009 Apr; 22(4):579-88. PubMed ID: 19270648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of PinX1 protein is correlated with tumor development and is a new independent poor prognostic factor in ovarian carcinoma.
    Cai MY; Zhang B; He WP; Yang GF; Rao HL; Rao ZY; Wu QL; Guan XY; Kung HF; Zeng YX; Xie D
    Cancer Sci; 2010 Jun; 101(6):1543-9. PubMed ID: 20367640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAP3K3 overexpression is associated with poor survival in ovarian carcinoma.
    Jia W; Dong Y; Tao L; Pang L; Ren Y; Liang W; Jiang J; Cheng G; Zhang WJ; Yuan X; Li F
    Hum Pathol; 2016 Apr; 50():162-9. PubMed ID: 26997451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of BTG3 was linked to carcinogenesis, aggressiveness, and prognosis of ovarian carcinoma.
    Deng B; Zhao Y; Gou W; Chen S; Mao X; Takano Y; Zheng H
    Tumour Biol; 2013 Oct; 34(5):2617-24. PubMed ID: 23657964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
    Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
    Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.